您的位置: 首页 > 农业专利 > 详情页

DOZAVIMO REŽIMAS, SKIRTAS IŠSĖTINEI SKLEROZEI
专利权人:
Ltd.;Yeda Research and Development Co.
发明人:
KLINGER, Ety
申请号:
LT17157735
公开号:
LT3199172T
申请日:
2010.08.19
申请国别(地区):
LT
年份:
2018
代理人:
摘要:
A method of alleviating a symptom of relapsing-remitting multiple sclerosis in a human patient suffering from relapsing-remitting multiple sclerosis or a patient who has experienced a first clinical episode and is determined to be at high risk of developing clinically definite multiple sclerosis comprising administering to the human patient three subcutaneous injections of a therapeutically effective dose of glatiramer acetate over a period of seven days with at least one day between every subcutaneous injection so as to thereby alleviate the symptom of the patient.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充